We are live on ! Find out more
DFO

Duquesne Family Office Portfolio holdings

AUM $3.38B
1-Year Est. Return 61.92%
This Fund
S&P 500
This Quarter Est. Return
+13.95%
1 Year Est. Return
+61.92%
3 Year Est. Return
+280.57%
5 Year Est. Return
+393.65%
10 Year Est. Return
+4,147.23%
AUM
$2.95B
AUM Growth
+$34.9M
Cap. Flow
-$266M
Cap. Flow %
-9%
Top 10 Hldgs %
62.64%
Holding
97
New
33
Increased
11
Reduced
20
Closed
22

Top Buys

Rank Stock Value
1
NTRA icon
Natera
NTRA
+$183M
2
KRE icon
State Street SPDR S&P Regional Banking ETF
KRE
+$113M
3
AVGO icon
Broadcom
AVGO
+$38.5M
4
ASND icon
Ascendis Pharma A/S
ASND
+$35.8M
5
NVT icon
nVent Electric
NVT
+$31.1M

Top Sells

Rank Stock Value
1
VST icon
Vistra
VST
+$190M
2
MSFT icon
Microsoft
MSFT
+$153M
3
KMI icon
Kinder Morgan
KMI
+$87.2M
4
MAA icon
Mid-America Apartment Communities
MAA
+$61.8M
5
OPCH icon
Option Care Health
OPCH
+$51.8M

Sector Composition

Rank Sector Weight
1 Technology 21.46%
2 Healthcare 21.04%
3 Consumer Discretionary 15.34%
4 Industrials 9.47%
5 Financials 8.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KEY icon
51
KeyCorp
KEY
$24.4B
$9.78M 0.33%
+583,900
New +$9.26M
FHN icon
52
First Horizon
FHN
$12.1B
$9.62M 0.33%
+619,700
New +$9.84M
ABCB icon
53
Ameris Bancorp
ABCB
$5.89B
$9.61M 0.33%
+154,000
New +$9.01M
FCNCA icon
54
First Citizens BancShares
FCNCA
$25.3B
$9.54M 0.32%
+5,183
New +$9.89M
YPF icon
55
YPF Sociedad Anonima American Depositary Shares (Each representing ten (10) Class D shares of Capital Stock)
YPF
$19.3B
$9.12M 0.31%
430,100
-208,335
-33% -$4.44M
SPRY icon
56
ARS Pharmaceuticals
SPRY
$612M
$7.79M 0.26%
+536,900
New +$6.39M
GEV icon
57
GE Vernova
GEV
$264B
$7.46M 0.25%
29,250
-267,818
-90% -$51.4M
SLN
58
Silence Therapeutics
SLN
$564M
$7.04M 0.24%
387,400
– –
ACLX
59
DELISTED
Arcellx
ACLX
$6.19M 0.21%
74,100
– –
TRP icon
60
TC Energy
TRP
$65.9B
$5.49M 0.19%
+115,400
New +$5.02M
SBUX icon
61
Starbucks
SBUX
$120B
$5.1M 0.17%
+52,305
New +$4.49M
XPO icon
62
XPO
XPO
$23.7B
$5M 0.17%
+46,500
New +$5.2M
PCVX icon
63
Vaxcyte
PCVX
$8.64B
$4.91M 0.17%
+42,965
New +$3.87M
WDC icon
64
Western Digital
WDC
$150B
$4.88M 0.17%
+94,469
New +$4.77M
NAMS icon
65
NewAmsterdam Pharma
NAMS
$3.34B
$4.77M 0.16%
+287,535
New +$4.97M
RARE icon
66
Ultragenyx Pharmaceutical
RARE
$2.55B
$4.75M 0.16%
+85,445
New +$4.35M
BCYC
67
Bicycle Therapeutics
BCYC
$292M
$4.3M 0.15%
190,200
– –
ARM icon
68
Arm
ARM
$302B
$3.09M 0.1%
+21,610
New +$3.07M
IHS icon
69
IHS Holding
IHS
$2.81B
$2.3M 0.08%
770,310
– –
TLSI icon
70
TriSalus Life Sciences
TLSI
$345M
$1.97M 0.07%
426,921
– –
PLTR icon
71
Palantir
PLTR
$413B
$1.55M 0.05%
41,710
-728,255
-95% -$22.4M
INSM icon
72
Insmed
INSM
$28.6B
$1.46M 0.05%
20,000
– –
NRIX icon
73
Nurix Therapeutics
NRIX
$2.65B
$993K 0.03%
44,200
– –
IVVD icon
74
Invivyd
IVVD
$218M
$583K 0.02%
571,425
– –
JOBY icon
75
Joby Aviation
JOBY
$8.55B
$113K ﹤0.01%
22,492
– –
1 2
3
4

Similar funds

VFCM
Valley Forge Capital Management Miami, Florida $3.38B AUM 15.93% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
EFM
E Fund Management Guangzhou, China $3.37B AUM
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return
5NCM
59 North Capital Management Houston, Texas $3.35B AUM 22.14% 1-Year Est. Return
MCM
Marsico Capital Management Denver, Colorado $3.4B AUM 51.58% 1-Year Est. Return
QCG
Quadrant Capital Group Cincinnati, Ohio $3.34B AUM 29.16% 1-Year Est. Return

Duquesne Family Office's Q3 2024 Portfolio in Review

As of Q3 2024, Duquesne Family Office held 97 positions worth $2.95B, up 1.2% from $2.92B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Duquesne Family Office withdrew a net $266M in Q3 2024, closing 22 positions and reducing 20 holdings. Its most notable exit was Option Care Health, an estimated $51.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Duquesne Family Office opened a new position in State Street SPDR S&P Regional Banking ETF worth $116M.

  • Duquesne Family Office's largest Q3 2024 buy was State Street SPDR S&P Regional Banking ETF: 2,053,323 shares worth $116M.
  • Duquesne Family Office added most to Natera in Q3 2024, an estimated $183M increase.
  • Duquesne Family Office's biggest Q3 2024 reduction was Vistra, cutting an estimated $190M.
  • Duquesne Family Office fully exited Option Care Health in Q3 2024, selling an estimated $51.8M.
  • Duquesne Family Office's ten largest holdings make up 63% of its $2.95B portfolio in Q3 2024.
  • Duquesne Family Office opened 33 new positions and closed 22 in Q3 2024.
  • Duquesne Family Office's portfolio value rose 1.2% quarter-over-quarter to $2.95B.

Based on Duquesne Family Office's 13F filing for Q3 2024, filed 14 Nov 2024.